Royal London Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.18M Sell
76,028
-9,132
-11% -$502K 0.01% 563
2025
Q1
$6.02M Buy
85,160
+8,301
+11% +$587K 0.01% 537
2024
Q4
$5.05M Sell
76,859
-486
-0.6% -$31.9K 0.01% 553
2024
Q3
$5.44M Buy
77,345
+4,058
+6% +$285K 0.01% 543
2024
Q2
$6.03M Buy
73,287
+1,090
+2% +$89.7K 0.02% 504
2024
Q1
$6.31M Sell
72,197
-1,620
-2% -$141K 0.02% 504
2023
Q4
$7.12M Buy
73,817
+1,917
+3% +$185K 0.02% 465
2023
Q3
$6.36M Buy
71,900
+3,624
+5% +$321K 0.02% 457
2023
Q2
$5.92M Buy
68,276
+5,444
+9% +$472K 0.02% 472
2023
Q1
$6.11M Sell
62,832
-1,070
-2% -$104K 0.02% 419
2022
Q4
$6.61M Hold
63,902
0.03% 398
2022
Q3
$5.42M Sell
63,902
-277
-0.4% -$23.5K 0.03% 412
2022
Q2
$5.32M Sell
64,179
-121
-0.2% -$10K 0.02% 433
2022
Q1
$4.96M Buy
64,300
+3,597
+6% +$277K 0.02% 501
2021
Q4
$5.37M Sell
60,703
-2,119
-3% -$187K 0.02% 471
2021
Q3
$4.86M Sell
62,822
-2,078
-3% -$161K 0.02% 493
2021
Q2
$5.42M Hold
64,900
0.02% 489
2021
Q1
$4.9M Hold
64,900
0.02% 498
2020
Q4
$5.69M Sell
64,900
-359
-0.6% -$31.5K 0.03% 410
2020
Q3
$4.96M Sell
65,259
-26
-0% -$1.98K 0.03% 404
2020
Q2
$7.98M Sell
65,285
-4,226
-6% -$516K 0.06% 293
2020
Q1
$5.73M Hold
69,511
0.05% 328
2019
Q4
$5.88M Hold
69,511
0.04% 374
2019
Q3
$4.69M Sell
69,511
-802
-1% -$54.1K 0.04% 433
2019
Q2
$6.02M Hold
70,313
0.06% 317
2019
Q1
$6.24M Sell
70,313
-6,379
-8% -$566K 0.05% 361
2018
Q4
$6.41M Buy
76,692
+4,842
+7% +$405K 0.06% 338
2018
Q3
$6.97M Sell
71,850
-336
-0.5% -$32.6K 0.07% 271
2018
Q2
$6.8M Buy
+72,186
New +$6.8M 0.07% 298
2016
Q2
$4.32M Sell
55,482
-3,085,046
-98% -$240M 0.07% 290
2016
Q1
$38K Buy
3,140,528
+3,084,821
+5,538% +$37.3K 0.05% 357
2015
Q4
$5.89M Sell
55,707
-749
-1% -$79.2K 0.09% 237
2015
Q3
$5.95M Buy
+56,456
New +$5.95M 0.1% 226
2014
Q4
$42K Buy
46,488
+12,066
+35% +$10.9K 0.08% 271
2014
Q3
$2.51M Buy
34,422
+2,075
+6% +$151K 0.06% 317
2014
Q2
$2.11M Sell
32,347
-133
-0.4% -$8.66K 0.05% 392
2014
Q1
$1.93M Buy
+32,480
New +$1.93M 0.04% 426